# Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)

> **NCT05312177** · — · COMPLETED · sponsor: **Carelon Research** · enrollment: 273 (actual)

## Conditions studied

- Down Syndrome
- Congenital Heart Disease

## Interventions

- **OTHER:** Stanford Binet Intelligence Scales, Fifth Edition
- **OTHER:** Vineland Adaptive Behavior Scales Third Edition
- **OTHER:** Peabody Picture Vocabulary Test, Fifth Edition
- **OTHER:** Expressive Vocabulary Test, Third Edition
- **OTHER:** Leiter International Performance Scale, Third Edition
- **OTHER:** Social Communication Questionnaire, Current Form
- **OTHER:** Aberrant Behavior Checklist
- **OTHER:** Repetitive Behavior Scale, Revised

## Key facts

- **NCT ID:** NCT05312177
- **Lead sponsor:** Carelon Research
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 273 (ACTUAL)
- **Last updated:** 2024-01-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05312177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05312177, "Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05312177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*